speb/financial-data huggingface dataset:
NCI balance_sheet (quarterly, 2024-12-31) — Invested Capital: 83932193.00
NCI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -19167148.00
NCI balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
NCI balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 0.00
NCI cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 65641784.00
NCI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 222497624.00
NCI balance_sheet (annual, 2024-12-31) — Leases: 5999129.00
NCI balance_sheet (quarterly, 2024-12-31) — Leases: 5999129.00
NCI balance_sheet (annual, 2024-12-31) — Line Of Credit: 27105722.00
NCI balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 27105722.00
NCI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 38601323.00
NCI balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 38601323.00
NCI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 38601323.00
NCI balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 38601323.00
NCI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 222497624.00
NCI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -226145302.00
NCI balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
NCI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 858303.00
NCI balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 858303.00
NCI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 65641784.00
NCI balance_sheet (annual, 2024-12-31) — Net Debt: 17939702.00
NCI balance_sheet (quarterly, 2024-12-31) — Net Debt: 17939702.00
NCI income_statement (annual, 2024-12-31) — Net Income: 8063331.00
NCI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 8063331.00
NCI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 8063331.00
NCI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 8063331.00
NCI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 8063331.00
NCI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 8063331.00
NCI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 8063331.00
NCI cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -15023180.00
NCI income_statement (annual, 2024-12-31) — Net Interest Income: -3727078.00
NCI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -3647678.00
NCI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -3647678.00
NCI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3727078.00
NCI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -40102988.00
NCI balance_sheet (annual, 2024-12-31) — Net PPE: 47237883.00
NCI balance_sheet (quarterly, 2024-12-31) — Net PPE: 47237883.00
NCI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4143968.00
NCI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 43285029.00
NCI balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 43285029.00
NCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 206806.00
NCI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 206806.00
NCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 920142.00
NCI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 920142.00
NCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 206806.00
NCI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 206806.00
NCI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 920142.00
NCI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 920142.00
NCI income_statement (annual, 2024-12-31) — Normalized EBITDA: 15075255.00
NCI income_statement (annual, 2024-12-31) — Normalized Income: 8063331.00
NCI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 428243.00
NCI income_statement (annual, 2024-12-31) — Operating Income: 11571424.00
NCI income_statement (annual, 2024-12-31) — Operating Revenue: 235667734.00
NCI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 508000.00
NCI balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 508000.00
NCI balance_sheet (annual, 2024-12-31) — Other Current Assets: 3589.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 3589.00
NCI balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 27105722.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 27105722.00
NCI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 998965.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 998965.00
NCI income_statement (annual, 2024-12-31) — Other Gand A: 7707452.00
NCI income_statement (annual, 2024-12-31) — Other Income Expense: 1304894.00
NCI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 13541442.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 13541442.00
NCI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2326379.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 2326379.00
NCI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1304894.00
NCI balance_sheet (annual, 2024-12-31) — Other Payable: 3770255.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Payable: 3770255.00
NCI balance_sheet (annual, 2024-12-31) — Other Properties: 42491805.00
NCI balance_sheet (quarterly, 2024-12-31) — Other Properties: 42491805.00
NCI balance_sheet (annual, 2024-12-31) — Payables: 7216074.00
NCI balance_sheet (quarterly, 2024-12-31) — Payables: 7216074.00
NCI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8303552.00
NCI balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 8303552.00
NCI balance_sheet (annual, 2024-12-31) — Prepaid Assets: 24384141.00
NCI balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 24384141.00
NCI income_statement (annual, 2024-12-31) — Pretax Income: 9149240.00
NCI balance_sheet (annual, 2024-12-31) — Properties: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
NCI income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 1253368.00
NCI cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1276953.00
NCI cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -15023180.00
NCI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4143968.00
NCI balance_sheet (annual, 2024-12-31) — Receivables: 35164611.00
NCI balance_sheet (quarterly, 2024-12-31) — Receivables: 35164611.00
NCI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 186223181.00
NCI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2166983.00
NCI income_statement (annual, 2024-12-31) — Rent And Landing Fees: 3866322.00
NCI income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 3866322.00
NCI cash_flow (annual, 2024-12-31) — Repayment Of Debt: -226145302.00
NCI balance_sheet (annual, 2024-12-31) — Retained Earnings: -50268270.00
NCI balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -50268270.00
NCI income_statement (annual, 2024-12-31) — Salaries And Wages: 18486483.00
NCI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 4392521.00
NCI income_statement (annual, 2024-12-31) — Selling General And Administration: 34452778.00
NCI balance_sheet (annual, 2024-12-31) — Share Issued: 508000.00
NCI balance_sheet (quarterly, 2024-12-31) — Share Issued: 508000.00
NCI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 56826471.00
NCI balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 56826471.00
NCI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 43285029.00
NCI balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 43285029.00
NCI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NCI income_statement (annual, 2024-12-31) — Tax Provision: 1085909.00
NCI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.12
NCI balance_sheet (annual, 2024-12-31) — Taxes Receivable: 994950.00
NCI balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 994950.00
NCI balance_sheet (annual, 2024-12-31) — Total Assets: 135647692.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Assets: 135647692.00
NCI balance_sheet (annual, 2024-12-31) — Total Capitalization: 56826471.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 56826471.00
NCI balance_sheet (annual, 2024-12-31) — Total Debt: 69597527.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Debt: 69597527.00
NCI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 56826471.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 56826471.00
NCI income_statement (annual, 2024-12-31) — Total Expenses: 224096310.00
NCI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 78821221.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 78821221.00
NCI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 63312510.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 63312510.00
NCI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 39521465.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 39521465.00
NCI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 11571424.00
NCI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2807576.00
NCI balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2807576.00
NCI balance_sheet (annual, 2024-12-31) — Working Capital: 33035426.00
NCI balance_sheet (quarterly, 2024-12-31) — Working Capital: 33035426.00
NCI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 13889041.00
NCI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -3702711.00
NCI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 106085870.00
NCI balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -376389.00
NCI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 45493013.00
NCI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 9906.00
NCI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1870477.00
NCI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1870477.00
NCI balance_sheet (quarterly, 2025-06-30) — Common Stock: 9906.00
NCI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 58183862.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 543739.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Assets: 69209855.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 5189781.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Debt: 23243451.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 28433232.00
NCI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 37443132.00
NCI balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 1553069.00
NCI balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 0.00
NCI balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5457566.00
NCI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 320088.00
NCI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12299800.00
NCI balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 14265430.00
NCI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 56965368.00
NCI balance_sheet (quarterly, 2025-06-30) — Inventory: 5457566.00
NCI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 81427313.00
NCI balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 352068.00
NCI balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 352068.00
NCI balance_sheet (quarterly, 2025-06-30) — Leases: 7693004.00
NCI balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 23243451.00
NCI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 40303232.00
NCI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 40303232.00
NCI balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 352068.00
NCI balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3779351.00
NCI balance_sheet (quarterly, 2025-06-30) — Net Debt: 21372974.00
NCI balance_sheet (quarterly, 2025-06-30) — Net PPE: 53262657.00
NCI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 45884062.00
NCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 62104.00
NCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1836297.00
NCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 62104.00
NCI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1836297.00
NCI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 508000.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3980.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 320088.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 12299800.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2580039.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Payable: 6548539.00
NCI balance_sheet (quarterly, 2025-06-30) — Other Properties: 45493013.00
NCI balance_sheet (quarterly, 2025-06-30) — Payables: 8466161.00
NCI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9009900.00
NCI balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 45354369.00
NCI balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
NCI balance_sheet (quarterly, 2025-06-30) — Receivables: 16523463.00
NCI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -48232002.00
NCI balance_sheet (quarterly, 2025-06-30) — Share Issued: 508000.00
NCI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 58183862.00
NCI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 45884062.00
NCI balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1081353.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Assets: 137766523.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 58183862.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Debt: 68736464.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 58183862.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 79582661.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 68556668.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 42139529.00
NCI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1917622.00
NCI balance_sheet (quarterly, 2025-06-30) — Working Capital: 31766723.00
NCI income_statement (annual, 2025-12-31) — +Operating Expense: 48880670.00
NCI income_statement (annual, 2025-12-31) — +Total Revenue: 137247341.00
NCI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7285278.00
NCI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7285278.00
NCI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4047426.00
NCI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4047426.00
NCI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 106085870.00
NCI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 106085870.00
NCI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -465974.00
NCI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -465974.00
NCI income_statement (annual, 2025-12-31) — Amortization: 2497004.00
NCI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 2497004.00
NCI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 2497004.00
NCI income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 2497004.00
NCI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 9166020.00
NCI cash_flow (annual, 2025-12-31) — Capital Expenditure: -4007964.00
NCI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 41682405.00
NCI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 41682405.00
NCI balance_sheet (annual, 2025-12-31) — Capital Stock: 9906.00
NCI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 9906.00
NCI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2332891.00
NCI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2332891.00
NCI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2332891.00
NCI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2332891.00
NCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -22825245.00
NCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4007964.00
NCI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 21374779.00
NCI cash_flow (annual, 2025-12-31) — Change In Account Payable: 0.00
NCI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1939466.00
NCI cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 310431.00
NCI cash_flow (annual, 2025-12-31) — Change In Inventory: -8081271.00
NCI cash_flow (annual, 2025-12-31) — Change In Payable: 310431.00
NCI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2249897.00
NCI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -6506352.00
NCI cash_flow (annual, 2025-12-31) — Change In Receivables: 30127670.00
NCI cash_flow (annual, 2025-12-31) — Change In Tax Payable: 310431.00
NCI cash_flow (annual, 2025-12-31) — Change In Working Capital: 17789944.00
NCI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 29132720.00
NCI cash_flow (annual, 2025-12-31) — Changes In Cash: -5458430.00
NCI balance_sheet (annual, 2025-12-31) — Common Stock: 9906.00
NCI balance_sheet (quarterly, 2025-12-31) — Common Stock: 9906.00
NCI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 56599404.00
NCI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 56599404.00
NCI cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
NCI income_statement (annual, 2025-12-31) — Cost Of Revenue: 86561692.00
NCI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1148365.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1148365.00
NCI balance_sheet (annual, 2025-12-31) — Current Assets: 52567423.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Assets: 52567423.00
NCI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4810410.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4810410.00
NCI balance_sheet (annual, 2025-12-31) — Current Debt: 4756671.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Debt: 4756671.00
NCI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 9567081.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 9567081.00
NCI balance_sheet (annual, 2025-12-31) — Current Liabilities: 20145933.00
NCI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 20145933.00
NCI cash_flow (annual, 2025-12-31) — Deferred Income Tax: 1136205.00
NCI cash_flow (annual, 2025-12-31) — Deferred Tax: 1136205.00
NCI cash_flow (annual, 2025-12-31) — Depreciation: 1735470.00
NCI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4232474.00
NCI income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4232474.00
NCI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4232474.00
NCI income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 4232474.00
NCI income_statement (annual, 2025-12-31) — Depreciation Income Statement: 1735470.00
NCI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 331679.00
NCI balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 1443971.00
NCI balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 1443971.00
NCI balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 480183.00
NCI balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 480183.00
NCI income_statement (annual, 2025-12-31) — EBIT: 3127798.00
NCI income_statement (annual, 2025-12-31) — EBITDA: 7360272.00
NCI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -1374699.00
NCI cash_flow (annual, 2025-12-31) — End Cash Position: 2332891.00
NCI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -22825245.00
NCI balance_sheet (annual, 2025-12-31) — Finished Goods: 12114712.00
NCI balance_sheet (quarterly, 2025-12-31) — Finished Goods: 12114712.00
NCI cash_flow (annual, 2025-12-31) — Free Cash Flow: 17366815.00
NCI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 440219.00
NCI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 440219.00
NCI income_statement (annual, 2025-12-31) — General And Administrative Expense: 40223230.00
NCI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 11044438.00
NCI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 11044438.00
NCI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 7751252.00
NCI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 7751252.00
NCI balance_sheet (annual, 2025-12-31) — Gross PPE: 53167062.00
NCI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 53167062.00
NCI income_statement (annual, 2025-12-31) — Gross Profit: 50685649.00
NCI income_statement (annual, 2025-12-31) — Interest Expense: 1349488.00
NCI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1349488.00
NCI income_statement (annual, 2025-12-31) — Interest Income: 0.00
NCI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 0.00
NCI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1349488.00
NCI balance_sheet (annual, 2025-12-31) — Inventory: 12114712.00
NCI balance_sheet (quarterly, 2025-12-31) — Inventory: 12114712.00
NCI balance_sheet (annual, 2025-12-31) — Invested Capital: 61356075.00
NCI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 61356075.00
NCI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4007964.00
NCI balance_sheet (annual, 2025-12-31) — Investments And Advances: 318134.00
NCI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 318134.00
NCI balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 318134.00
NCI balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 318134.00
NCI cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
NCI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 67242051.00
NCI balance_sheet (annual, 2025-12-31) — Leases: 7758478.00
NCI balance_sheet (quarterly, 2025-12-31) — Leases: 7758478.00
NCI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 36871995.00
NCI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 36871995.00
NCI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36871995.00
NCI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36871995.00
NCI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 67242051.00
NCI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -89591102.00
NCI balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 318134.00
NCI balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 318134.00
NCI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3726179.00
NCI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3726179.00
NCI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
NCI balance_sheet (annual, 2025-12-31) — Net Debt: 2423780.00
NCI balance_sheet (quarterly, 2025-12-31) — Net Debt: 2423780.00
NCI income_statement (annual, 2025-12-31) — Net Income: 331679.00
NCI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 331679.00
NCI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 331679.00
NCI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 331679.00
NCI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 331679.00
NCI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 331679.00
NCI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 331679.00
NCI cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
NCI income_statement (annual, 2025-12-31) — Net Interest Income: -1349488.00
NCI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -22349051.00
NCI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -22349051.00
NCI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1349488.00
NCI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -476194.00
NCI balance_sheet (annual, 2025-12-31) — Net PPE: 49119636.00
NCI balance_sheet (quarterly, 2025-12-31) — Net PPE: 49119636.00
NCI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4007964.00
NCI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 45554966.00
NCI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 45554966.00
NCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 72592.00
NCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 72592.00
NCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2014423.00
NCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2014423.00
NCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 72592.00
NCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 72592.00
NCI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2014423.00
NCI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2014423.00
NCI income_statement (annual, 2025-12-31) — Normalized EBITDA: 7360272.00
NCI income_statement (annual, 2025-12-31) — Normalized Income: 331679.00
NCI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 21374779.00
NCI income_statement (annual, 2025-12-31) — Operating Income: 1804979.00
NCI income_statement (annual, 2025-12-31) — Operating Revenue: 137247341.00
NCI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 508002.00
NCI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 508002.00
NCI balance_sheet (annual, 2025-12-31) — Other Current Assets: 4920.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4920.00
NCI balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4756671.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4756671.00
NCI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 440219.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 440219.00
NCI income_statement (annual, 2025-12-31) — Other Gand A: 11027677.00
NCI income_statement (annual, 2025-12-31) — Other Income Expense: 1322819.00
NCI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 11044438.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 11044438.00
NCI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2509532.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2509532.00
NCI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1322819.00
NCI balance_sheet (annual, 2025-12-31) — Other Payable: 5036396.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Payable: 5036396.00
NCI balance_sheet (annual, 2025-12-31) — Other Properties: 41682405.00
NCI balance_sheet (quarterly, 2025-12-31) — Other Properties: 41682405.00
NCI balance_sheet (annual, 2025-12-31) — Payables: 9430487.00
NCI balance_sheet (quarterly, 2025-12-31) — Payables: 9430487.00
NCI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10578852.00
NCI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10578852.00
NCI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 29385651.00
NCI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 29385651.00
NCI income_statement (annual, 2025-12-31) — Pretax Income: 1778310.00
NCI balance_sheet (annual, 2025-12-31) — Properties: 0.00
NCI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
NCI income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: -2143178.00
NCI cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -2115523.00
NCI cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
NCI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4007964.00
NCI balance_sheet (annual, 2025-12-31) — Receivables: 8729249.00
NCI balance_sheet (quarterly, 2025-12-31) — Receivables: 8729249.00
NCI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 86561692.00
NCI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4232474.00
NCI income_statement (annual, 2025-12-31) — Rent And Landing Fees: 7440152.00
NCI income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 7440152.00
NCI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -89591102.00
NCI balance_sheet (annual, 2025-12-31) — Retained Earnings: -49936591.00
NCI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -49936591.00
NCI income_statement (annual, 2025-12-31) — Salaries And Wages: 21755401.00
NCI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 6568144.00
NCI income_statement (annual, 2025-12-31) — Selling General And Administration: 46791374.00
NCI balance_sheet (annual, 2025-12-31) — Share Issued: 508002.00
NCI balance_sheet (quarterly, 2025-12-31) — Share Issued: 508002.00
NCI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 56599404.00
NCI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 56599404.00
NCI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 45554966.00
NCI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 45554966.00
NCI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NCI income_statement (annual, 2025-12-31) — Tax Provision: 1446631.00
NCI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
NCI balance_sheet (annual, 2025-12-31) — Taxes Receivable: 0.00
NCI balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 0.00
NCI balance_sheet (annual, 2025-12-31) — Total Assets: 115631755.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Assets: 115631755.00
NCI balance_sheet (annual, 2025-12-31) — Total Capitalization: 56599404.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 56599404.00
NCI balance_sheet (annual, 2025-12-31) — Total Debt: 46439076.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Debt: 46439076.00
NCI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 56599404.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 56599404.00
NCI income_statement (annual, 2025-12-31) — Total Expenses: 135442362.00
NCI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 59032351.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 59032351.00
NCI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 63064332.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 63064332.00
NCI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 38886418.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 38886418.00
NCI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1804979.00
NCI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3913908.00
NCI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3913908.00
NCI balance_sheet (annual, 2025-12-31) — Working Capital: 32421490.00
NCI balance_sheet (quarterly, 2025-12-31) — Working Capital: 32421490.00
NCI.V balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -36741.00
NCI.V income_statement (annual, 2021-12-31) — Amortization: 131222.00
NCI.V income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 131222.00
NCI.V income_statement (annual, 2021-12-31) — Basic Average Shares: 29494471.00
NCI.V income_statement (annual, 2021-12-31) — Basic EPS: 0.05
NCI.V cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -1552.00
NCI.V cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -133797.00
NCI.V cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -1631974.00
NCI.V balance_sheet (annual, 2021-12-31) — Current Debt: 1168911.00
NCI.V balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 0.00
NCI.V balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 0.00
NCI.V income_statement (annual, 2021-12-31) — Diluted Average Shares: 31989471.00
NCI.V income_statement (annual, 2021-12-31) — Diluted EPS: 0.05
NCI.V balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 3035110.00
NCI.V cash_flow (annual, 2021-12-31) — Issuance Of Debt: 161000.00
NCI.V cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 161000.00
NCI.V balance_sheet (annual, 2021-12-31) — Net Debt: 7597367.00
NCI.V cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1451381.00
NCI.V balance_sheet (annual, 2021-12-31) — Other Current Assets: 55764.00
NCI.V balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 542843.00
NCI.V income_statement (annual, 2021-12-31) — Other Special Charges: 133098.00
NCI.V income_statement (annual, 2021-12-31) — Provision For Doubtful Accounts: 21524.00
NCI.V cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1451381.00
NCI.V balance_sheet (annual, 2021-12-31) — Receivables Adjustments Allowances: 0.00
NCI.V income_statement (annual, 2021-12-31) — Write Off: 21524.00
NCI.V income_statement (annual, 2022-12-31) — +Operating Expense: 4939928.00
NCI.V income_statement (annual, 2022-12-31) — +Total Revenue: 17652313.00
NCI.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 1488841.00
NCI.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3163233.00
NCI.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1817685.00
NCI.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2617273.00
NCI.V balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -25057.00
NCI.V income_statement (annual, 2022-12-31) — Amortization: 277416.00
NCI.V cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 277416.00
NCI.V cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 277416.00
NCI.V income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 277416.00
NCI.V income_statement (annual, 2022-12-31) — Basic Average Shares: 29594471.00
NCI.V income_statement (annual, 2022-12-31) — Basic EPS: 0.05
NCI.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 158870.00
NCI.V balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 29556.00
NCI.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -1430520.00
NCI.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 39004.00
NCI.V balance_sheet (annual, 2022-12-31) — Capital Stock: 13606986.00
NCI.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 725020.00
NCI.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 725020.00
NCI.V cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
NCI.V balance_sheet (annual, 2022-12-31) — Cash Financial: 725020.00
NCI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -216985.00
NCI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1430520.00
NCI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2213655.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Account Payable: 445040.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 38333.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 16510.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Payable: 724707.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 445040.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -22305.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Receivables: -134474.00
NCI.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 343104.00
NCI.V cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -134474.00
NCI.V cash_flow (annual, 2022-12-31) — Changes In Cash: 566150.00
NCI.V balance_sheet (annual, 2022-12-31) — Common Stock: 13606986.00
NCI.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: -6777128.00
NCI.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 25000.00
NCI.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 10929917.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2406070.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Assets: 4710722.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 39004.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Debt: 1244334.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1283338.00
NCI.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 8268605.00
NCI.V cash_flow (annual, 2022-12-31) — Depreciation: 160795.00
NCI.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 438211.00
NCI.V income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 438211.00
NCI.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 438211.00
NCI.V income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 438211.00
NCI.V income_statement (annual, 2022-12-31) — Depreciation Income Statement: 160795.00
NCI.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 33137471.00
NCI.V income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
NCI.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1247857.00
NCI.V balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 1608735.00
NCI.V income_statement (annual, 2022-12-31) — EBIT: 1569317.00
NCI.V income_statement (annual, 2022-12-31) — EBITDA: 2007528.00
NCI.V cash_flow (annual, 2022-12-31) — End Cash Position: 725020.00
NCI.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: -216985.00
NCI.V balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -822757.00
NCI.V cash_flow (annual, 2022-12-31) — Free Cash Flow: 783135.00
NCI.V income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
NCI.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -294625.00
NCI.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -822757.00
NCI.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 4237457.00
NCI.V balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 3205601.00
NCI.V balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3188290.00
NCI.V balance_sheet (annual, 2022-12-31) — Gross PPE: 2068973.00
NCI.V income_statement (annual, 2022-12-31) — Gross Profit: 6722396.00
NCI.V income_statement (annual, 2022-12-31) — Insurance And Claims: 480172.00
NCI.V income_statement (annual, 2022-12-31) — Interest Expense: 321460.00
NCI.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 321460.00
NCI.V cash_flow (annual, 2022-12-31) — Interest Paid Cff: -315656.00
NCI.V balance_sheet (annual, 2022-12-31) — Invested Capital: 1143340.00
NCI.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1430520.00
NCI.V balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
NCI.V balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 25000.00
NCI.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 121311.00
NCI.V balance_sheet (annual, 2022-12-31) — Land And Improvements: 0.00
NCI.V balance_sheet (annual, 2022-12-31) — Line Of Credit: 389321.00
NCI.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
NCI.V balance_sheet (annual, 2022-12-31) — Long Term Debt: 6676134.00
NCI.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 6676134.00
NCI.V cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 121311.00
NCI.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -90560.00
NCI.V balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
NCI.V balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2039417.00
NCI.V cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 25000.00
NCI.V balance_sheet (annual, 2022-12-31) — Net Debt: 7195448.00
NCI.V income_statement (annual, 2022-12-31) — Net Income: 1247857.00
NCI.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1247857.00
NCI.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1247857.00
NCI.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1247857.00
NCI.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1247857.00
NCI.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 788434.00
NCI.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1247857.00
NCI.V cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1302221.00
NCI.V income_statement (annual, 2022-12-31) — Net Interest Income: -321460.00
NCI.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 73671.00
NCI.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 30751.00
NCI.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -321460.00
NCI.V balance_sheet (annual, 2022-12-31) — Net PPE: 251288.00
NCI.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -128299.00
NCI.V cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 42920.00
NCI.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -9982729.00
NCI.V income_statement (annual, 2022-12-31) — Normalized EBITDA: 2302153.00
NCI.V income_statement (annual, 2022-12-31) — Normalized Income: 1465260.79
NCI.V balance_sheet (annual, 2022-12-31) — Notes Receivable: 17431.00
NCI.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2213655.00
NCI.V income_statement (annual, 2022-12-31) — Operating Income: 1782468.00
NCI.V income_statement (annual, 2022-12-31) — Operating Revenue: 17652313.00
NCI.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 29594471.00
NCI.V balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 855013.00
NCI.V income_statement (annual, 2022-12-31) — Other Gand A: 249306.00
NCI.V income_statement (annual, 2022-12-31) — Other Income Expense: -213152.00
NCI.V balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 3205601.00
NCI.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 315656.00
NCI.V income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 81473.00
NCI.V balance_sheet (annual, 2022-12-31) — Other Payable: 647311.00
NCI.V balance_sheet (annual, 2022-12-31) — Other Receivables: 422114.00
NCI.V income_statement (annual, 2022-12-31) — Other Special Charges: -50020.00
NCI.V balance_sheet (annual, 2022-12-31) — Payables: 4579197.00
NCI.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 6985267.00
NCI.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 86751.00
NCI.V income_statement (annual, 2022-12-31) — Pretax Income: 1247857.00
NCI.V balance_sheet (annual, 2022-12-31) — Properties: 0.00
NCI.V income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1302221.00
NCI.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -128299.00
NCI.V balance_sheet (annual, 2022-12-31) — Receivables: 3898951.00
NCI.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 10929917.00
NCI.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 438211.00
NCI.V income_statement (annual, 2022-12-31) — Rent And Landing Fees: 114484.00
NCI.V income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 114484.00
NCI.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -90560.00
NCI.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -22178630.00
NCI.V income_statement (annual, 2022-12-31) — Salaries And Wages: 3393495.00
NCI.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 264260.00
NCI.V income_statement (annual, 2022-12-31) — Selling General And Administration: 4501717.00
NCI.V balance_sheet (annual, 2022-12-31) — Share Issued: 29594471.00
NCI.V income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
NCI.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 328250.00
NCI.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: -6777128.00
NCI.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: -9982729.00
NCI.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -77221.21
NCI.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
NCI.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 296173.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Assets: 8167611.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Capitalization: -100994.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Debt: 7959472.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -6777128.00
NCI.V income_statement (annual, 2022-12-31) — Total Expenses: 15869845.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 14944739.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3456889.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 6676134.00
NCI.V income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 2254305.00
NCI.V balance_sheet (annual, 2022-12-31) — Total Tax Payable: 834310.00
NCI.V income_statement (annual, 2022-12-31) — Total Unusual Items: -294625.00
NCI.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -294625.00
NCI.V balance_sheet (annual, 2022-12-31) — Working Capital: -3557883.00
NCI.V income_statement (annual, 2022-12-31) — Write Off: 0.00
NCI.V income_statement (annual, 2023-12-31) — +Operating Expense: 6381761.00
NCI.V income_statement (annual, 2023-12-31) — +Total Revenue: 27728117.00
NCI.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 1869195.00
NCI.V balance_sheet (annual, 2023-12-31) — Accounts Receivable: 5781049.00
NCI.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1891509.00
NCI.V balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2711523.00
NCI.V balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -66606.00
NCI.V income_statement (annual, 2023-12-31) — Amortization: 421218.00
NCI.V cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 421218.00
NCI.V cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 421218.00
NCI.V income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 421218.00
NCI.V cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 66606.00